Skip to content

PrEP would save the NHS money, in numerous scenarios

Restrictions on free DAA access in many European countries contrary to guidelines and undermine HCV elimination targets, say researchers

MSM in London diagnosed with early syphilis are a priority group for PrEP, suggests UK study

Symtuza protease inhibitor regimen maintains viral suppression for a year

Long-acting monoclonal antibody effective against multidrug-resistant HIV

Rapid fibrosis progression in large proportion of HIV-positive gay men after acute HCV

Impact of side-effects on retention in HIV care is underestimated, African study suggests

Many gay/bisexual men currently taking PrEP would switch to injectable forms of the therapy should it become available

People with HIV/HCV co-infection have an increased risk of cardiovascular disease compared to people with HIV alone